Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Importancia ginecológica del istmocele ¿cómo y cuándo tratar?

Gynecological importance of the isthmocele ¿When and how to treat?

Ginecol Obstet Mex. 2017 feb;85(2):55-63.


Melo-Cerda I

Ginecoobstetra, encargado de la Unidad de Colposcopia, Centro Estatal de Oncología del Estado de Sonora, Hermosillo, Sonora, México.


Corrrespondencia:

Dr. Isaac Melo Cerda
imeloc1@live.com

Debe citarse como:

Melo-Cerda I. Importancia ginecológica del istmocele ¿cómo y cuándo tratar? Ginecol Obstet Mex 2017 feb;85(2):55-63.

Resumen

OBJETIVO: determinar la incidencia de defectos en el cierre de la histerorrafia, sus síntomas y analizar las conductas terapéuticas.

MATERIALES Y MÉTODOS: estudio observacional, prospectivo y comparativo de pacientes con defectos en el cierre de la histerorrafia, atendidas en la Clínica de Colposcopia del Centro Estatal de Oncología del Estado de Sonora entre el 1 de enero de 2013 y el 31 de diciembre de 2015. Criterios de inclusión: pacientes con citología anormal y antecedente de cesárea, a quienes se practicaron: colposcopia, endocervicocolposcopia e histeroscopia. Criterios de exclusión: problemas técnicos que impidieron la observación del canal endocervical o la histeroscopia, pacientes posmenopáusicas, y las que tuvieran diagnóstico colposcópico de cáncer invasor.

RESULTADOS: se estudiaron 120 pacientes con antecedente de cesárea, que se practicó en diferentes centros hospitalarios, de éstas se excluyeron 25 y quedaron 95 casos: 62 (65%) del grupo A (con defectos en el cierre de la histerorrafia) y 33 (35%) del grupo B (sin defectos en el cierre de la histerorrafia). De los 62 casos con defectos en el cierre de la histerorrafia, 30 (50%) fueron en el cierre de la histerorrafia tipo cúpula, 20 (31%) tipo divertículo y 12 (19%) dehiscencia total. Hubo manchado menstrual en 73% de las pacientes, polimenorrea en 31% y dismenorrea en 33%.  Solo 20% de las pacientes sintomáticas refirieron los síntomas como relevantes. El aumento de la vascularidad y el sangrado se encontraron en las pacientes con más síntomas.

PALABRAS CLAVE: istmocele, defecto en el cierre de la histerorrafia, cicatriz de cesárea, sangrado uterino anormal, manchado menstrual, dehiscencia de histerorrafia.

Abstract

OBJECTIVE: The Cesarean Scar Defect (CSD) has been underestimated in frequency and importance. Is necessary to know its incidence, the symptoms, and analyze new therapeutic procedures.

MATERIAL AND METHODS: Observational, prospective and comparative study of patients with defects in the closure of hysterorrhaphy, attended at the Colposcopy Clinic of the State Oncology Center of the State of Sonora between January 1, 2013 and December 31, 2015. Inclusion criteria: Patients with abnormal cytology and previous cesarean section, who were: colposcopy, endocervicocolposcopy and hysteroscopy. Exclusion criteria: technical problems that prevented observation of the endocervical canal or hysteroscopy, postmenopausal patients, and those with a colposcopic diagnosis of invasive cancer.

RESULTS: We found in 65.2%, spotting in a 73.3%, polymenorrhea at 31.3%, and to dysmenorrhea in 32.3%. Only 20% of the symptomatic patients referred the symptom as Relevant. We found “CSDs producers of bleeding” that are related to the patients more systematic.

CONCLUSIONS: The cesarean scar defects are frequent cause of gynecological symptomatology that is irrelevant most of the time. A small number of patients needs treatment, we found CSD that produce bleeding, this cases present relevant symptomatology and require treatment. It is necessary to take this into account to choose the best therapeutic approach.

KEY WORDS: Isthmocele; Cesarean scare defect; Cesarean scare; Abnormal uterine bleeding; Postmenstrual spotting; Wound dehiscence.

    1. Morlando M, et al. Placenta Accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand 2013;92:457-60.
    2. Higgins MF, et al. Real increasing incidence of Hysterectomy for placenta accrete following previous cesarean section. Eur J Obstet Gynecol Reprod Biol 2013;171:54-56.
    3. Torre AM, Frishman GN. Cesarean scar defects: an under recognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol 2013;20(5):562-72.
    4. Talamonte VH, et al. Hysteroscopy findings in patients with post-menstrual spotting with prior cesarean section. Eistein (Sao Pablo) 2012;10(1):53-6.
    5. Roberge S, Boutin A. Systematic review of cesarean scar assessment in the nonpregnant state: imaging techniques and uterine scar defect. AmJ Perinatol 2012;29(6):465-71.
    6. 6. Melo I. Defecto en el cierre de la histerorrafia. Ginecol Obstet Mex 2014;82:530-34.
    7. Uppal T, et al. Sonographically detected caesarean section scar defects and menstrual irregularity. J Obstet Gynecol 2011; 31(5):413-16.
    8. Wang CB, Chiu WW. Cesarean scar defect: correlation between cesarean section number, defect size, clinical symptoms and uterine position. Ultrasound Obstet Gynecol. 2009 Jul;34(1):85-9.
    9. Gubbini G, et al. Surgical hysteroscopic treatment of cesarean-induced isthmocele in restoring fertility: a prospective study. J Minim Invasive Gynecol 2011;18:234-237.
    10. Melo I. Endocervicocolposcopia: método exploratorio complementario a la colposcopia. Mostrando su efectividad. Revista de Enfermedades del Tracto Genital Inferior. 2013;7(1):5-11.
    11. Shih CL. Hysteroscopic transcervical resection. A straight forward method corrects bleeding related to cesarean section scar. Am J Obstet Gynecol 2011 Mar;204(3):278.e1-278.e2.
    12. Bij de Vaate, et al. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstet Gynecol 2011;37:91-99.
    13. Feng, et al. Hysteroscopic treatment of postcesarean scar defect. J Minim Invasive Gynecol 2012;19(4):498-502.
    14. Klemm P, Koehler C, Exprimevacas M, Schneider T, Schneider A. Laparoscopic and vaginal repair of uterine scar dehiscence following cesarean section as detected by ultrasound. J Perinat Med 2005;33(4):324-31.
    15. Chang Y. Resectoscopic treatment combined with sonohysterographic evaluation of woman postmenstrual bleeding as a result of previous cesarean delivery scar defect. Am J Obstet Gynecol. 2009;200(4):370.e1-370.e4.
    16. Osser OV, Cesarean section scar defects: agreement between transvaginal sonographic findings with and without saline contrast enhancement. Ultrasound Obstet Gynecol 2010;35(1):75-83.
    17. Marotta ML, Donnez J, Squifflet J, Jadoul P, Darii N, Donnez O. Laparoscopic repair of post-cesarean section uterine scar defects diagnosed in nonpregnant women. J Minim Invasive Gynecol 2013;20(3):387-91.
    18. Roberge S. Impact of single- vs double-layer closure on adverse outcomes and uterine scar defect: a systematic review and metaanalysis. A J Obstet Gynecol 2014;211(5):453-60.
    19. Bujold y col. The impact of single-layer closure on uterine ruptura. Obstetrics 2002;186:1326-30.
    20. Khoshnow Q y col. Transvaginal repair of caesarean scar dehiscence. Aust N Z J Obstet Gynecol 2010;50(1):94-5.
    21. Lou L. Vaginal repair of cesarean section scar diverticula. J Minim Invasive Gynecol 2012;19(4):454-8.
    22. Jastrow N y col. Impact of labor at prior cesarean on lower uterine segment thickness in subsequent pregnancy. Am J Obstet Gynecol 2010;202(6): 563.e1-7.
    23. Bij de Vaate AJ. Prevalence, potential risk factors for development and syntoms relates to the presence of uterine niches following Cesarean section: sintomatic review. Ultrasound Obstet Gynecol 2014;43(4): 372-82.
    24. Morris H. Surgical pathology of the lower uterine segment caesarean section scar: is the scar a source of clinical symptoms? Int J Gynecol Pathol 1995;14(1):16-20.

Comentarios